Lupus trials recruiting in Connecticut
5
Recruiting in Connecticut
2
Cities with sites
Cities in Connecticut
New Haven 4Farmington 1
Recruiting trials in Connecticut
- A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Rheumatology Patient Registry and Biorepository
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- VIBRANT: VIB4920 for Active Lupus Nephritis